Tracon Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Tracon Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q2 2024.
  • Tracon Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.84M, a 54.8% increase year-over-year.
  • Tracon Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $5.2M.
  • Tracon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.59M, a 87.7% increase from 2022.
  • Tracon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$29.1M, a 1.63% decline from 2021.
  • Tracon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$28.7M, a 70.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $5.2M -$2.84M +$3.45M +54.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.75M -$3.17M +$5.34M +62.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-13
Q4 2023 -$3.59M $439K +$7.44M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$11M $10.8M +$17.2M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$28.2M -$6.29M -$56K -0.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$28.2M -$8.5M +$969K +10.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-13
Q4 2022 -$29.1M -$7M +$715K +9.27% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$29.9M -$6.44M +$517K +7.44% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$30.4M -$6.23M +$2.71M +30.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$33.1M -$9.47M -$4.41M -87.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$28.7M -$7.71M -$3.4M -78.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 -$25.3M -$6.95M -$2.96M -74.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$22.3M -$8.94M -$4.49M -101% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$17.8M -$5.06M -$1.04M -25.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$16.8M -$4.31M -$375K -9.53% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-08
Q3 2020 -$16.4M -$3.99M +$1.21M +23.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$17.6M -$4.45M +$1.88M +29.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-03
Q1 2020 -$19.5M -$4.02M +$3.19M +44.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-03
Q4 2019 -$22.7M -$3.94M +$3.82M +49.3% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-28
Q3 2019 -$26.5M -$5.2M +$3.89M +42.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$30.4M -$6.33M +$3.43M +35.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$33.8M -$7.21M +$1.15M +13.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-10
Q4 2018 -$35M -$7.76M -$1.2M -18.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$33.8M -$9.09M -$10.3M -876% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-28
Q2 2018 -$23.5M -$9.75M -$3.19M -48.6% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-28
Q1 2018 -$20.3M -$8.36M -$1.22M -17% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-28
Q4 2017 -$19.1M -$6.56M -$246K -3.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$18.9M $1.17M +$7.04M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 -$25.9M -$6.57M +$1.73M +20.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 -$27.6M -$7.15M -$621K -9.52% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 -$27M -$6.31M +$4.73M +42.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$31.7M -$5.87M +$576K +8.93% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$32.3M -$8.3M -$5.38M -184% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 -$26.9M -$6.53M -$2.5M -62.1% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 -$24.4M -$11M -$8.5M -333% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-01
Q3 2015 -$15.9M -$6.45M -$4.53M -236% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-01
Q2 2015 -$11.4M -$2.92M -$1.94M -198% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-01
Q1 2015 -$9.47M -$4.03M -$2.67M -196% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-01
Q4 2014 -$6.81M -$2.55M Oct 1, 2014 Dec 31, 2014 10-K 2016-02-19
Q3 2014 -$1.92M Jul 1, 2014 Sep 30, 2014 10-K 2016-02-19
Q2 2014 -$980K Apr 1, 2014 Jun 30, 2014 10-K 2016-02-19
Q1 2014 -$1.36M Jan 1, 2014 Mar 31, 2014 10-K 2016-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.